Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
J Bone Miner Res. 2020 Oct;35(10):1904-1913. doi: 10.1002/jbmr.4096. Epub 2020 Jun 22.
Advanced glycation end-products (AGEs), which bind to type 1 collagen in bone and skin, have been implicated in reduced bone quality. The AGE reader™ measures skin autofluorescence (SAF), which might be regarded as a marker of long-term accumulation of AGEs in tissues. We investigated the association of SAF with bone mineral density (BMD) and fractures in the general population. We studied 2853 individuals from the Rotterdam Study with available SAF measurements (median age, 74.1 years) and with data on prevalent major osteoporotic (MOFs: hip, humerus, wrist, clinical vertebral) and vertebral fractures (VFs: clinical + radiographic Genant's grade 2 and 3). Radiographs were assessed 4 to 5 years before SAF. Multivariate regression models were performed adjusted for age, sex, BMI, creatinine, smoking status, and presence of diabetes and additionally for BMD with interaction terms to test for effect modification. Prevalence of MOFs was 8.5% and of VFs 7%. SAF had a curvilinear association with prevalent MOFs and VFs and therefore, age-adjusted, sex stratified SAF quartiles were used. The odds ratio (OR) (95% confidence interval [CI]) of the second, third and fourth quartiles of SAF for MOFs were as follows: OR 1.60 (95% CI, 1.08-2.35; p = .02); OR 1.30 (95% CI, 0.89-1.97; p = .20), and OR 1.40 (95% CI, 0.95-2.10; p = .09), respectively, with first (lowest) quartile as reference. For VFs the ORs were as follows: OR 1.69 (95% CI, 1.08-2.64; p = .02), OR 1.74(95% CI, 1.11-2.71; p = .01), and OR 1.73 (95% CI, 1.12-2.73; p = .02) for second, third, and fourth quartiles, respectively. When comparing the top three quartiles combined with the first quartile, the OR (95% CI) for MOFs was 1.43 (95% CI, 1.04-2.00; p = .03) and for VFs was 1.72 (95% CI, 1.18-2.53; p = .005). Additional adjustment for BMD did not change the associations. In conclusion, there is evidence of presence of a threshold of skin AGEs below which there is distinctly lower prevalence of fractures. Longitudinal analyses are needed to confirm our cross-sectional findings. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.
晚期糖基化终产物(AGEs)与骨骼和皮肤中的 1 型胶原结合,与骨质量降低有关。AGE 阅读器™ 测量皮肤自发荧光(SAF),这可能被视为组织中 AGE 长期积累的标志物。我们调查了 SAF 与一般人群中骨矿物质密度(BMD)和骨折之间的关联。我们研究了 Rotterdam 研究中的 2853 名参与者,这些参与者有可用的 SAF 测量值(中位年龄 74.1 岁),并且有关于常见的主要骨质疏松症(MOFs:髋部、肱骨、腕部、临床椎体)和椎体骨折(VF:临床+放射学 Genant 等级 2 和 3)的数据。在 SAF 测量前 4 至 5 年进行了 X 光检查。进行了多变量回归模型,调整了年龄、性别、BMI、肌酐、吸烟状况以及糖尿病的存在,并根据 BMD 进行了调整,以测试交互作用是否存在效应修饰。MOF 的患病率为 8.5%,VF 的患病率为 7%。SAF 与普遍存在的 MOF 和 VF 呈曲线关联,因此,使用年龄调整、性别分层的 SAF 四分位数。MOF 的 SAF 第二、第三和第四四分位数的比值比(OR)(95%置信区间[CI])如下:OR 1.60(95%CI,1.08-2.35;p =0.02);OR 1.30(95%CI,0.89-1.97;p =0.20)和 OR 1.40(95%CI,0.95-2.10;p =0.09),分别以第一(最低)四分位数为参考。对于 VFs,OR 如下:OR 1.69(95%CI,1.08-2.64;p =0.02),OR 1.74(95%CI,1.11-2.71;p =0.01),和 OR 1.73(95%CI,1.12-2.73;p =0.02),分别为第二、第三和第四四分位数。当比较前三个四分位数与第一个四分位数时,MOF 的 OR(95%CI)为 1.43(95%CI,1.04-2.00;p =0.03),VF 的 OR 为 1.72(95%CI,1.18-2.53;p =0.005)。对 BMD 的额外调整并没有改变这些关联。总之,有证据表明皮肤 AGE 存在一个阈值,低于该阈值,骨折的患病率明显降低。需要进行纵向分析来证实我们的横断面研究结果。2020 年美国骨与矿物研究协会出版。